Here are three things to know:
1. Tyber Medical’s private label partners plan to begin launching products for the Australian market in the third quarter of 2016.
2. Tyber Medical, an original equipment manufacturer, designs and develops class II orthopedic systems.
3. Most recently, the company’s BioTy, a modified surface treatment, received FDA clearance.
More articles on devices:
33 organizations implore Congress to postpone CMS equipment proposal: 5 things to know
Simplifying orthopedics in a complex industry — Dr. Joe Kohli changes the game with [m]pirik
InVivo Therapeutics shares mission on radio broadcast — 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
